535 related articles for article (PubMed ID: 26852852)
1. Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets.
Badawy SI; Narang AS; LaMarche KR; Subramanian GA; Varia SA; Lin J; Stevens T; Shah PA
J Pharm Sci; 2016 Jan; 105(1):168-81. PubMed ID: 26852852
[TBL] [Abstract][Full Text] [Related]
2. Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy.
Badawy SI; Lin J; Gokhale M; Desai S; Nesarikar VV; LaMarche KR; Subramanian GA; Narang AS
Int J Pharm; 2014 Jul; 469(1):111-20. PubMed ID: 24780101
[TBL] [Abstract][Full Text] [Related]
3. Quality by design approach for formulation development: a case study of dispersible tablets.
Charoo NA; Shamsher AA; Zidan AS; Rahman Z
Int J Pharm; 2012 Feb; 423(2):167-78. PubMed ID: 22209997
[TBL] [Abstract][Full Text] [Related]
4. Real-time assessment of granule densification in high shear wet granulation and application to scale-up of a placebo and a brivanib alaninate formulation.
Narang AS; Sheverev VA; Stepaniuk V; Badawy S; Stevens T; Macias K; Wolf A; Pandey P; Bindra D; Varia S
J Pharm Sci; 2015 Mar; 104(3):1019-34. PubMed ID: 25470221
[TBL] [Abstract][Full Text] [Related]
5. Quality by design case study: an integrated multivariate approach to drug product and process development.
Huang J; Kaul G; Cai C; Chatlapalli R; Hernandez-Abad P; Ghosh K; Nagi A
Int J Pharm; 2009 Dec; 382(1-2):23-32. PubMed ID: 19664698
[TBL] [Abstract][Full Text] [Related]
6. System-wide hybrid MPC-PID control of a continuous pharmaceutical tablet manufacturing process via direct compaction.
Singh R; Ierapetritou M; Ramachandran R
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1164-82. PubMed ID: 23523542
[TBL] [Abstract][Full Text] [Related]
7. Pharmaceutical quality by design: product and process development, understanding, and control.
Yu LX
Pharm Res; 2008 Apr; 25(4):781-91. PubMed ID: 18185986
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic basis for the effects of process parameters on quality attributes in high shear wet granulation.
Badawy SI; Narang AS; LaMarche K; Subramanian G; Varia SA
Int J Pharm; 2012 Dec; 439(1-2):324-33. PubMed ID: 22981985
[TBL] [Abstract][Full Text] [Related]
9. Application of quality by design to the development of analytical separation methods.
Orlandini S; Pinzauti S; Furlanetto S
Anal Bioanal Chem; 2013 Jan; 405(2-3):443-50. PubMed ID: 22941176
[TBL] [Abstract][Full Text] [Related]
10. Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process.
Hubert C; Lebrun P; Houari S; Ziemons E; Rozet E; Hubert P
J Pharm Biomed Anal; 2014 Jan; 88():401-9. PubMed ID: 24176744
[TBL] [Abstract][Full Text] [Related]
11. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets.
Fonteyne M; Wickström H; Peeters E; Vercruysse J; Ehlers H; Peters BH; Remon JP; Vervaet C; Ketolainen J; Sandler N; Rantanen J; Naelapää K; De Beer T
Eur J Pharm Biopharm; 2014 Jul; 87(2):252-63. PubMed ID: 24589422
[TBL] [Abstract][Full Text] [Related]
12. Implementation of Quality by Design (QbD) for development of bilayer tablets.
Simão J; Chaudhary SA; Ribeiro AJ
Eur J Pharm Sci; 2023 May; 184():106412. PubMed ID: 36828037
[TBL] [Abstract][Full Text] [Related]
13. Application of In-line Focused Beam Reflectance Measurement to Brivanib Alaninate Wet Granulation Process to Enable Scale-up and Attribute-based Monitoring and Control Strategies.
Narang AS; Stevens T; Macias K; Paruchuri S; Gao Z; Badawy S
J Pharm Sci; 2017 Jan; 106(1):224-233. PubMed ID: 27771049
[TBL] [Abstract][Full Text] [Related]
14. Critical factors in manufacturing multi-layer tablets--assessing material attributes, in-process controls, manufacturing process and product performance.
Vaithiyalingam SR; Sayeed VA
Int J Pharm; 2010 Oct; 398(1-2):9-13. PubMed ID: 20656000
[TBL] [Abstract][Full Text] [Related]
15. Systematical approach of formulation and process development using roller compaction.
Teng Y; Qiu Z; Wen H
Eur J Pharm Biopharm; 2009 Oct; 73(2):219-29. PubMed ID: 19406236
[TBL] [Abstract][Full Text] [Related]
16. Implementation of quality by design approach in manufacturing process optimization of dry granulated, immediate release, coated tablets - a case study.
Teżyk M; Jakubowska E; Milanowski B; Lulek J
Drug Dev Ind Pharm; 2017 Oct; 43(10):1626-1636. PubMed ID: 28481717
[TBL] [Abstract][Full Text] [Related]
17. A quality by design study applied to an industrial pharmaceutical fluid bed granulation.
Lourenço V; Lochmann D; Reich G; Menezes JC; Herdling T; Schewitz J
Eur J Pharm Biopharm; 2012 Jun; 81(2):438-47. PubMed ID: 22446063
[TBL] [Abstract][Full Text] [Related]
18. Implementation of Quality by Design for Formulation of Rebamipide Gastro-retentive Tablet.
Ha JM; Seo JW; Kim SH; Kim JY; Park CW; Rhee YS; Park ES
AAPS PharmSciTech; 2017 Nov; 18(8):3129-3139. PubMed ID: 28526986
[TBL] [Abstract][Full Text] [Related]
19. Quality by Design: Concept to Applications.
Swain S; Parhi R; Jena BR; Babu SM
Curr Drug Discov Technol; 2019; 16(3):240-250. PubMed ID: 29521238
[TBL] [Abstract][Full Text] [Related]
20. Process optimization of a novel immediate release film coating system using QbD principles.
Teckoe J; Mascaro T; Farrell TP; Rajabi-Siahboomi AR
AAPS PharmSciTech; 2013 Jun; 14(2):531-40. PubMed ID: 23483430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
